applying for approval
Scope
Date
~
-
Beauty & Cosmetics
Amorepacific's camellia-derived cosmetic ingredients get COSMOS
South Korean cosmetics giant Amorepacific Corp. said on Thursday its camellia-derived cosmetic ingredients got COSMetic Organic and natural Standard...
Nov 10, 2023 (Gmt+09:00)
-
Banking & Finance
Woori Bank to add two new branches in India 2024
South Korea's Woori Bank plans to open two new branches in India in the first half of next year. The bank announced on Tuesday it has obtained ...
Oct 31, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean to design digital vessels with ABS
South Korea’s Hanwha Ocean Co. on Sunday announced its conclusion of a basic accord with the Houston-based American Bureau of Shipping (ABS) t...
Oct 30, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai develops electric propulsion system for large ships
HD Korea Shipbuilding & Offshore Engineering and HD Hyundai Heavy Industries Co. have secured Approval in Principle (AIP) from the UK's Lloyd's ...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Theraject Asia applies for microneedle patent in US
South Korean microneedle company Theraject Asia on Thursday said it recently applied for a US patent for a medical microneedle, specifically a const...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Oct 19, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
KT, Hyundai Livart to pursue DX in home interior
South Korea’s KT Corp. and furniture and interior company Hyundai Livart Furniture are pursuing Premium Interior Digital Transformation (DX), ...
Oct 12, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor, Kia to adopt Tesla’s charging standard for EVs
Hyundai Motor Co. and Kia Corp. have joined Tesla's Supercharger network for electric vehicles (EV).The North American branches of the two South Kor...
Oct 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets sales approval for Yuflyma in Japan
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...
Sep 26, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Korean Air may give up Asiana’s cargo business, 4 routes for EU approval
Korean Air Lines Co. may give up the cargo business of Asiana Airlines Inc. and four of its lucrative routes in Europe in an all-in bet as the marri...
Sep 25, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio applies for US patent of early diagnosis tech of dementia
South Korean medical diagnostic company NGeneBio Co. announced on Thursday that it has completed the US patent application for its technology relate...
Sep 14, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Artificial intelligence
Samsung to apply GenAI to all home appliances from 2024
BERLIN, GERMANY - Samsung Electronics Co. from next year will incorporate generative artificial intelligence (GenAI) into all home appliances and de...
Sep 04, 2023 (Gmt+09:00)
-
Energy
Land use for SK Ecoplant's wind power venture in Canada approved
The green hydrogen Nujio’qonik project in Canada, a venture that South Korea's SK Ecoplant is taking part in, has secured approval to use go...
Sep 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Hugel resubmits application to FDA for botulinum toxin product
South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...
Sep 01, 2023 (Gmt+09:00)
-
Energy
Hyundai Steel's offshore wind power plant gets int’l certification
South Korea’s Hyundai Steel on Wednesday said its Ulsan Factory 2 in the southern coastal city of Ulsan received certification as an offshore ...
Aug 31, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
SM Korealine gets self-sailing approval from Panama
SM Korealine Co., a unit of SM Group's maritime division, announced on Monday that its subsidiary Korealine LNG, has obtained approval for self-sail...
Aug 28, 2023 (Gmt+09:00)
-
Blockchain
BC Card to develop NFT as used luxury item receipt
South Korea’s BC Card on Sunday said it has applied for two domestic patents for payment receipt-based non-fungible token (NFT) technology to ...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong applies for approval of Envlo in Saudi Arabia
South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...
Aug 25, 2023 (Gmt+09:00)
-
Artificial intelligence
Naver eyes global market with new LLM HyperCLOVA X
Naver Corp., the South Korean online platform giant, has finally debuted its upgraded large language model (LLM) HyperCLOVA X, its new pillar busine...
Aug 24, 2023 (Gmt+09:00)
-
Energy
Poland kicks off approval process to import S.Korean reactors
Poland has started an approval process to build a nuclear power plant consisting of South Korean reactors, according to foreign media reports, despi...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience resumes output of flu vaccine after two years
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)